ニュース
It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me ...
A cancer thriver reflects on the emotional toll, survivorship, advocacy and support networks they wish they’d known at ...
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...
I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, ...
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.
CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.
Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic ...
Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek ...
Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...
Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.
Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する